Dr. F. Perry Wilson, associate professor at the Yale School of Medicine, manages a program called "DOM-CoV-X" – Yale’s proprietary COVID-19 Explorer.
- February 23, 2023
Yale provides cardiovascular risk assessment and treatment for patients with autoimmune diseases, including rheumatoid arthritis, systemic lupus, scleroderma, psoriatic arthritis, and vasculitis.
- February 17, 2023Source: Today
F. Perry Wilson, MD, MSCE, discusses what to look for when choosing a primary care doctor.
- February 10, 2023
Hyperspectral Imaging Provides Novel Way to Quantify Raynaud Phenomenon in Systemic Sclerosis Patients
A new study from Yale Department of Internal Medicine’s Section of Rheumatology, Allergy & Immunology and the Department of Surgery’s Division of Vascular Surgery and Endovascular Therapy described the use of hyperspectral imaging (HSI) to measure oxygenated and deoxygenated hemoglobin concentrations and oxygen saturation. In systemic sclerosis patients with Raynaud phenomenon, this technology may help quantify disease severity.
- February 02, 2023
Groundbreaking clinical research at ACC 23.
- November 17, 2022Source: Medscape
Automated alerts sent to clinicians via patients' electronic health records (EHRs) identified patients with diagnosable acute kidney injury (AKI) who were taking one or more medications that could potentially further worsen their renal function. This led to a significant increase in discontinuations of the problematic drugs and better clinical outcomes in a subgroup of patients in a new multicenter, randomized study with more than 5000 participants.
- October 28, 2022
Most-read Content of October: All-cause Excess Mortality, SGLT2 Inhibitors & Drug Safety Regulatory Response
Recent developments from the Section of Cardiovascular Medicine.
- October 13, 2022
Guideline-directed medical therapies are under-utilized. Two trainees developed an interactive consult tool to provide guidance at each stage of kidney disease.
- October 06, 2022
Most-read Content of September: Using risk scores to improve patient outcomes, dual antiplatelet therapy, and more
The Section of Cardiovascular Medicine published research in American Heart Journal, JAMA Internal Medicine, and JAMA Cardiology.
- September 26, 2022
Cytokinetics Announces Upcoming Presentations at the 2022 Inaugural HCM Society Scientific Sessions and the HFSA Annual Scientific MeetingSource: Yahoo
The Heart Failure Society of America (HFSA) Annual Scientific Meeting will take place in Washington, D.C. from September 30, 2022 to October 3, 2022.